News

Pharmabiz12h
Corona Remedies acquires seven brands in cardiology & women’s healthcare from the pharmaceutical division of Bayer in India
Corona Remedies acquires seven brands in cardiology & women’s healthcare from the pharmaceutical division of Bayer in India: ...
Pharmabiz8h
NanoViricides designs trial protocol for phase II MPox Clade Ia with a novel drug NV-387 for treating MPox disease
Shelton, Connecticut Thursday, July 17, 2025, 18:00 Hrs [IST] ...
Pharmabiz10h
HLL Lifecare bolsters India's family welfare efforts with 221.7 crore annual condom production
HLL Lifecare bolsters India's family welfare efforts with 221.7 crore annual condom production: Our Bureau, Chennai Thursday, July 17, 2025, 16:15 Hrs [IST] HLL Lifecare Limited, ...
Pharmabiz11h
Aethlon Medical announces DSMB completes its scheduled safety review and recommended advancing to the next patient cohort without modification
The treatment of life-threatening viruses not addressed with approved therapies. The Hemopurifier is being developed under an open Investigational Device Exemption (IDE) for both indications.
Pharmabiz9h
Caranx Medical receives US FDA clearance for an AI-driven intra-operative software, Tavipilot Soft for US commercialization
Caranx Medical receives US FDA clearance for an AI-driven intra-operative software, Tavipilot Soft for US commercialization: Nice, France Thursday, July 17, 2025, 17:00 Hrs [IST] ...
Pharmabiz9h
JenaValve Technology doses first patient in ARTIST study for evaluating Trilogy system in patients with aortic regurgitation
JenaValve Technology doses first patient in ARTIST study for evaluating Trilogy system in patients with aortic regurgitation: Irvine, California Thursday, July 17, 2025, 16:30 Hrs ...
Pharmabiz11h
Kairos Pharma reports positive results from phase 2 trial of ENV-105 in advanced prostate cancer
Kairos Pharma reports positive results from phase 2 trial of ENV-105 in advanced prostate cancer: Los Angeles Thursday, July 17, 2025, 15:00 Hrs [IST] Kairos Pharma, Ltd., a clini ...
Pharmabiz13h
Akeso initiates patient enrolling in phase III trial of ivonescimab for first-line treatment of advanced metastatic colorectal cancer
Akeso initiates patient enrolling in phase III trial of ivonescimab for first-line treatment of advanced metastatic colorectal cancer: Hong Kong Thursday, July 17, 2025, 13:00 Hrs ...
Pharmabiz11h
Zeno Health launches nationwide e-commerce platform to deliver quality, affordable medicines across 23,000+ pin codes
Zeno Health launches nationwide e-commerce platform to deliver quality, affordable medicines across 23,000+ pin codes: Our Bureau, Bengaluru Thursday, July 17, 2025, 15:20 Hrs [IS ...
Pharmabiz10h
Celcuity receives US patent for its lead drug candidate, gedatolisib; getting exclusivity up to 2042
Celcuity receives US patent for its lead drug candidate, gedatolisib; getting exclusivity up to 2042: Minneapolis Thursday, July 17, 2025, 16:00 Hrs [IST] Minneapolis-headquartere ...
Pharmabiz16h
US FDA grants fast track designation to Sanofi’s SAR446597 to treat geographic atrophy due to age-related macular degeneration
US FDA grants fast track designation to Sanofi’s SAR446597 to treat geographic atrophy due to age-related macular degeneration: Paris Thursday, July 17, 2025, 10:00 Hrs [IST] Th ...
Pharmabiz11h
HOSMAC inks MoU with Gulf Medical University as industry partner to strengthen healthcare education
HOSMAC inks MoU with Gulf Medical University as industry partner to strengthen healthcare education: Our Bureau, Bengaluru Thursday, July 17, 2025, 14:45 Hrs [IST] HOSMAC, Asia’ ...